Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis: Vasculite Leucocitoclástica Cutânea Induzida por Inibidores da Tirosina-Cinase

Diogo Alpuim Costa; Susana Baptista de Almeida; Pedro Coelho Barata; António Quintela; Pedro Cabral; Ana Afonso; João Maia Silva

doi:10.29315/gm.v5i1.147

Diogo Alpuim Costa - Corresponding Author

Haematology and Oncology Department, Instituto CUF de Oncologia (ICO), Lisboa, Portugal.

Rua Professor Mário Botas, 1998-018 Lisboa, Portugal

Susana Baptista de Almeida

Oncology Department, Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal.

Pedro Coelho Barata

Experimental Therapeutics Fellow, Cleveland Clinic, Ohio, USA.

António Quintela

Haematology and Oncology Department, Instituto CUF de Oncologia (ICO), Lisboa, Portugal.

Pedro Cabral

Radiology Department, Instituto CUF de Oncologia (ICO), Lisboa, Portugal.

Ana Afonso

Pathology Department, Instituto CUF de Oncologia (ICO), Lisboa, Portugal.

João Maia Silva

Dermatology Department, Instituto CUF de Oncologia (ICO), Lisboa, Portugal.

Abstract

A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).

Keywords: Protein Kinase Inhibitors/adverse effects; Vasculitis, Leukocytoclastic, Cutaneous/chemically induced

1.

Costa DA, Almeida SB de, Barata PC, Quintela A, Cabral P, Afonso A, et al. Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis: Vasculite Leucocitoclástica Cutânea Induzida por Inibidores da Tirosina-Cinase. Gaz Med [Internet]. 2018 May 25 [cited 2024 Dec. 25];5(1):45-6. Available from: https://gazetamedica.pt/index.php/gazeta/article/view/147

Issue

ISSUE 1 · VOLUME 5 · JANUARY/MARCH 2018

Section

MEDICAL IMAGES